MD3319586T2 - Formulări farmaceutice pentru tratamentul afecțiunilor inflamatorii ale rectului - Google Patents

Formulări farmaceutice pentru tratamentul afecțiunilor inflamatorii ale rectului

Info

Publication number
MD3319586T2
MD3319586T2 MDE20180489T MDE20180489T MD3319586T2 MD 3319586 T2 MD3319586 T2 MD 3319586T2 MD E20180489 T MDE20180489 T MD E20180489T MD E20180489 T MDE20180489 T MD E20180489T MD 3319586 T2 MD3319586 T2 MD 3319586T2
Authority
MD
Moldova
Prior art keywords
rectum
treatment
pharmaceutical preparations
inflammatory conditions
formulation
Prior art date
Application number
MDE20180489T
Other languages
English (en)
Inventor
Rudolph Wilhelm
Markus Prols
Roland Greinwald
Ralf Mohrbacher
Original Assignee
Dr Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Falk Pharma Gmbh filed Critical Dr Falk Pharma Gmbh
Publication of MD3319586T2 publication Critical patent/MD3319586T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la o formulă farmaceutică stabilă la păstrare pentru administrare rectală, care conţine budesonidă sau o sare ori un derivat al acesteia compatibil din punct de vedere farmaceutic şi cel puţin 80% în greutate dintr-o grăsime solidă sau un amestec de diferite grăsimi solide în raport cu greutatea totală a formulării, precum şi cel puţin un agent antioxidant compatibil cu aceasta.
MDE20180489T 2015-07-08 2016-06-28 Formulări farmaceutice pentru tratamentul afecțiunilor inflamatorii ale rectului MD3319586T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15175806.7A EP3115037B1 (de) 2015-07-08 2015-07-08 Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms
PCT/EP2016/064907 WO2017005524A1 (de) 2015-07-08 2016-06-28 Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms

Publications (1)

Publication Number Publication Date
MD3319586T2 true MD3319586T2 (ro) 2023-04-30

Family

ID=53540667

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20180489T MD3319586T2 (ro) 2015-07-08 2016-06-28 Formulări farmaceutice pentru tratamentul afecțiunilor inflamatorii ale rectului

Country Status (23)

Country Link
US (3) US10905699B2 (ro)
EP (2) EP3115037B1 (ro)
JP (1) JP6857644B2 (ro)
CN (1) CN107847435B (ro)
AU (1) AU2016290343B2 (ro)
CA (1) CA2986081C (ro)
DK (1) DK3319586T3 (ro)
EA (1) EA033153B1 (ro)
ES (2) ES2688119T3 (ro)
FI (1) FI3319586T3 (ro)
HR (1) HRP20230174T1 (ro)
HU (1) HUE061585T2 (ro)
IL (1) IL255247B (ro)
LT (1) LT3319586T (ro)
MA (1) MA42367B1 (ro)
MD (1) MD3319586T2 (ro)
PL (1) PL3319586T3 (ro)
PT (2) PT3115037T (ro)
RS (1) RS64020B1 (ro)
SI (1) SI3319586T1 (ro)
UA (1) UA120075C2 (ro)
WO (1) WO2017005524A1 (ro)
ZA (1) ZA201707777B (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022226778A1 (zh) * 2021-04-27 2022-11-03 广州共禾医药科技有限公司 经直肠施用的奥司他韦或其药学上可接受的盐的药物组合物、及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB701831A (en) * 1950-10-19 1954-01-06 Rudolf Von Wuelfing Process for the production of suppositories containing medicaments
US3208907A (en) * 1961-11-13 1965-09-28 Lab Toraude Stabilized salicylate compositions
DE3709861A1 (de) * 1987-03-25 1988-10-06 Henkel Kgaa Emulgierende suppositoriengrundmassen und daraus hergestellte zaepfchen
JP2927830B2 (ja) * 1989-09-01 1999-07-28 東京田辺製薬株式会社 ダナゾール坐剤
IT1243379B (it) 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
DE29717252U1 (de) * 1997-09-26 1998-02-19 Falk Pharma Gmbh Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
CU23203A1 (es) * 2002-12-27 2007-05-18 Ct Ingenieria Genetica Biotech Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal
WO2008156671A2 (en) * 2007-06-13 2008-12-24 Jay Pravda Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
JP5223307B2 (ja) * 2006-11-17 2013-06-26 大正製薬株式会社 坐剤
WO2010062863A2 (en) * 2008-11-26 2010-06-03 Satiogen Pharmaceuticals, Inc. Compositions containing satiogens and methods of use
WO2012022796A2 (de) * 2010-08-20 2012-02-23 Boehringer Ingelheim International Gmbh Neue kombinationen
CN102525883B (zh) * 2010-12-09 2013-05-08 丽珠集团丽珠制药厂 一种伏立康唑栓剂及其制备方法和用途
WO2015073846A1 (en) 2013-11-15 2015-05-21 Salix Pharmaceuticals, Inc. Method of treating ulcerative colitis

Also Published As

Publication number Publication date
MA42367B1 (fr) 2023-02-28
ZA201707777B (en) 2018-11-28
CA2986081C (en) 2024-02-20
SI3319586T1 (sl) 2023-03-31
DK3319586T3 (da) 2023-02-27
CN107847435B (zh) 2021-07-27
EA201792685A1 (ru) 2018-07-31
MA42367A (fr) 2018-05-16
EP3319586A1 (de) 2018-05-16
PL3319586T3 (pl) 2023-05-08
HRP20230174T1 (hr) 2023-04-14
HUE061585T2 (hu) 2023-07-28
UA120075C2 (uk) 2019-09-25
IL255247A0 (en) 2017-12-31
JP6857644B2 (ja) 2021-04-14
EP3319586B1 (de) 2023-01-18
JP2018519345A (ja) 2018-07-19
FI3319586T3 (fi) 2023-03-22
US11738032B2 (en) 2023-08-29
US10905699B2 (en) 2021-02-02
ES2688119T3 (es) 2018-10-31
CN107847435A (zh) 2018-03-27
PT3319586T (pt) 2023-02-14
LT3319586T (lt) 2023-03-10
RS64020B1 (sr) 2023-03-31
ES2938358T3 (es) 2023-04-10
IL255247B (en) 2020-11-30
AU2016290343B2 (en) 2020-10-15
EP3115037A1 (de) 2017-01-11
PT3115037T (pt) 2018-10-22
EP3115037B1 (de) 2018-08-15
CA2986081A1 (en) 2017-01-12
WO2017005524A1 (de) 2017-01-12
US20180200268A1 (en) 2018-07-19
AU2016290343A1 (en) 2017-11-16
EA033153B1 (ru) 2019-09-30
US20230364113A1 (en) 2023-11-16
US20210100819A1 (en) 2021-04-08
NZ736749A (en) 2023-12-22

Similar Documents

Publication Publication Date Title
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
PE20180242A1 (es) Composiciones que comprenden cepas bacterianas
TW201613901A (en) New compounds
GEP20217247B (en) Indole derivatives for use in medicine
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MX2018003569A (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
PH12019501362A1 (en) Polymorphs
EA201790949A1 (ru) Замещенные 2,4-диаминохинолины в качестве новых противораковых средств
MX2019002057A (es) Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc.
MX2017001103A (es) Derivados de indolizina que son aplicables a enfermedades neurodegenerativas.
WO2016089206A3 (en) Selective il-6-trans-signalling inhibitor compositions
MX2020012800A (es) Cannabinoides y usos de los mismos.
DOP2017000085A (es) Derivados estabilizados de adrenomedulina y uso de los mismos
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
MX2015008733A (es) Derivados de 1,2,3-triazol-4-amina para el tratamiento de enfermedades y transtornos relacionados con receptores sigma.
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2017013278A (es) Odorante osmanthus.
NZ757526A (en) Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction
MD3319586T2 (ro) Formulări farmaceutice pentru tratamentul afecțiunilor inflamatorii ale rectului
MX2017004909A (es) Composiciones de triptamina y metodos de uso.
EA201691465A1 (ru) Средство для лечения сердечно-сосудистых заболеваний